Home › NDC Lookup › RxCUI directory › RxCUI 198245

Terconazole 80 MG Vaginal Insert — RxCUI 198245

RxNorm drug concept · Semantic clinical drug
RxCUI 198245 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198245
Official nameTerconazole 80 MG Vaginal Insert
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)10,196 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Terconazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Terconazole treats vaginal yeast infections — specifically those caused by a fungus called Candida. It comes as a vaginal cream or a vaginal suppository, and both work the same way...
  • You insert terconazole vaginally — either using the applicator with the cream or inserting the suppository — once each night at bedtime for three nights in a row. It is not taken b...
  • How do I use it, and how long does treatment last?
  • The most common side effects are headache, genital burning or itching, painful periods, and abdominal discomfort. These are generally manageable. However, if you develop skin irrit...
📖 Read our full Terconazole guide →

🕸️ Concept Web — How Terconazole 80 MG Vaginal Insert Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Terconazole 80 MG Vaginal Insert RxCUI 198245

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Terconazole 37806
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Terconazole Vaginal Insert 2109039
    • Terconazole Vaginal Product 1161498
    • Vaginal Insert 2107950
    • Vaginal Product 1151125
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Terconazole 80 MG 316770

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Terconazole 80 MG SCDC · 316770
  • Terconazole Vaginal Insert SCDF · 2109039
  • Terconazole Vaginal Product SCDG · 1161498

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 198245 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00713-0552-73 3 BLISTER PACK in 1 CARTON (0713-0552-73) / 1 SUPPOSITORY i... Terconazole Cosette Pharmaceuticals, Inc. 2015-09-25
45802-0717-08 3 BLISTER PACK in 1 CARTON (45802-717-08) / 1 SUPPOSITORY i... Terconazole Padagis Israel Pharmaceuticals Ltd 2006-08-28
51672-1330-03 1 DOSE PACK in 1 CARTON (51672-1330-3) / 3 SUPPOSITORY in 1... Terconazole Sun Pharmaceutical Industries, Inc. 2007-03-09
Observed labelers: Cosette Pharmaceuticals, Inc. (1) · Padagis Israel Pharmaceuticals Ltd (1) · Sun Pharmaceutical Industries, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$20.8653
Range $20.8653–$20.8653 · middle 50% $20.8653–$20.8653 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.